Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Sep 12, 2025

Accession no.
0001628280-25-041983
Filed
Sep 12, 2025
Trade date
Aug 1-29, 2025
Filing delay
42 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.52K. It was filed 42 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2025Common StockPPurchaseAcquired+68$3.44+$233.92288,413Direct
Aug 4, 2025Common StockPPurchaseAcquired+68$4.01+$272.68288,481Direct
Aug 5, 2025Common StockPPurchaseAcquired+68$3.92+$266.56288,549Direct
Aug 6, 2025Common StockPPurchaseAcquired+68$3.34+$227.12288,617Direct
Aug 7, 2025Common StockPPurchaseAcquired+68$3.14+$213.52288,685Direct
Aug 8, 2025Common StockPPurchaseAcquired+68$3.39+$230.52288,753Direct
Aug 11, 2025Common StockPPurchaseAcquired+68$2.87+$195.16288,821Direct
Aug 12, 2025Common StockPPurchaseAcquired+68$2.91+$197.88288,889Direct
Aug 13, 2025Common StockPPurchaseAcquired+68$2.94+$199.92288,957Direct
Aug 14, 2025Common StockPPurchaseAcquired+68$2.84+$193.12289,025Direct
Aug 15, 2025Common StockPPurchaseAcquired+68$3.02+$205.36289,093Direct
Aug 18, 2025Common StockPPurchaseAcquired+68$3.11+$211.48289,161Direct
Aug 19, 2025Common StockPPurchaseAcquired+68$3.23+$219.64289,229Direct
Aug 20, 2025Common StockPPurchaseAcquired+12$3.15+$37.8289,241Direct
Aug 21, 2025Common StockPPurchaseAcquired+68$3.31+$225.08289,309Direct
Aug 22, 2025Common StockPPurchaseAcquired+68$3.32+$225.76289,377Direct
Aug 25, 2025Common StockPPurchaseAcquired+68$3.32+$225.76289,445Direct
Aug 26, 2025Common StockPPurchaseAcquired+68$3.39+$230.52289,513Direct
Aug 27, 2025Common StockPPurchaseAcquired+68$3.44+$233.92289,581Direct
Aug 28, 2025Common StockPPurchaseAcquired+68$3.47+$235.96289,649Direct
Aug 29, 2025Common StockPPurchaseAcquired+68$3.45+$234.6289,717Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)